12:00 AM
 | 
Apr 01, 2013
 |  BC Week In Review  |  Company News  |  Deals

Retina Institute Japan, Dainippon Sumitomo deal

The companies will discuss partnering to develop Retina Institute Japan's induced pluripotent stem cell (iPSC)-derived retinal pigment epithelial cells to treat age-related macular degeneration...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >